English

Euthymics Bioscience, Inc.

EDGAR

Quarterly report (10-Q) · filed 2008-11-13

32 filing records in this dataset, filed from 2002-05-29 to 2008-11-13. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

500 thousand USD

2008-09-30 · USD

Exact inputs and evidence

Revenue: 500000 USD Source

Operating margin

-468.04%

2008-09-30 · %

Exact inputs and evidence

Operating Income: -2340188 USD Source
Revenue: 500000 USD Source

Operating cash flow

-929 thousand USD

2008-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: -8546173 USD Source
Operating Cash Flow: -7616838 USD Source

Cash and cash equivalents: 5.3 million USD 2008-09-30 Source
Exact value

5299522 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

3.84 million USD

2007-10-01 – 2008-09-30

Exact inputs and evidence

Revenue: 10229433 USD · 2007-01-01 – 2007-12-31 Source
Revenue: 8485703 USD · 2007-01-01 – 2007-09-30 Source
Revenue: 0 USD · 2008-01-01 – 2008-03-31 Source
Revenue: 1600000 USD · 2008-04-01 – 2008-06-30 Source
Revenue: 500000 USD · 2008-07-01 – 2008-09-30 Source

Net income

-9.02 million USD

2007-10-01 – 2008-09-30

Exact inputs and evidence

Net income: -7561739 USD · 2007-01-01 – 2007-12-31 Source
Net income: -6315329 USD · 2007-01-01 – 2007-09-30 Source
Net income: -3566787 USD · 2008-01-01 – 2008-03-31 Source
Net income: -1938471 USD · 2008-04-01 – 2008-06-30 Source
Net income: -2273102 USD · 2008-07-01 – 2008-09-30 Source

Operating cash flow

-9.54 million USD

2007-10-01 – 2008-09-30

Exact inputs and evidence

Operating cash flow: -14916506 USD · 2007-01-01 – 2007-12-31 Source
Operating cash flow: -13919355 USD · 2007-01-01 – 2007-09-30 Source
Operating cash flow: -6739197 USD · 2008-01-01 – 2008-03-31 Source
Operating cash flow: -7616838 USD · 2008-01-01 – 2008-06-30 Source
Operating cash flow: -6739197 USD · 2008-01-01 – 2008-03-31 Source
Operating cash flow: -8546173 USD · 2008-01-01 – 2008-09-30 Source
Operating cash flow: -7616838 USD · 2008-01-01 – 2008-06-30 Source

Capital expenditure

0 USD

2007-01-01 – 2007-12-31

Exact inputs and evidence

Capital expenditure: 0 USD · 2007-01-01 – 2007-03-31 Source
Capital expenditure: 0 USD · 2007-01-01 – 2007-06-30 Source
Capital expenditure: 0 USD · 2007-01-01 – 2007-03-31 Source
Capital expenditure: 0 USD · 2007-01-01 – 2007-09-30 Source
Capital expenditure: 0 USD · 2007-01-01 – 2007-06-30 Source
Capital expenditure: 0 USD · 2007-01-01 – 2007-12-31 Source
Capital expenditure: 0 USD · 2007-01-01 – 2007-09-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2008-11-13.

Financial data available through: 2007-12-31.

Coverage by financial measure

Revenue: 8 of 11 periods available· newest 2007-12-31
Operating income: 8 of 11 periods available· newest 2007-12-31
Net income: 8 of 11 periods available· newest 2007-12-31
Operating cash flow: 8 of 11 periods available· newest 2007-12-31
Capital expenditure: 8 of 11 periods available· newest 2007-12-31
Total assets: 7 of 11 periods available· newest 2007-12-31
liabilities: No compatible figures in this window
Current assets: 7 of 11 periods available· newest 2007-12-31
Current liabilities: 7 of 11 periods available· newest 2007-12-31
Cash and cash equivalents: 8 of 11 periods available· newest 2007-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-60.6%

Prior period

USD 25.95 million

2006-01-01 – 2006-12-31
Current period

USD 10.23 million

2007-01-01 – 2007-12-31

Exact inputs and evidence

10229433 − 25951443 = -15722010 USD

25951443 USD · 2006-01-01 – 2006-12-31
Inspect prior input Prior source
10229433 USD · 2007-01-01 – 2007-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · Euthymics Bioscience, Inc. · 2007-12-31 Euthymics Bioscience, Inc. (edgar:1066833) Year-over-year change in Revenue: -15722010 USD Concept: fundies:Revenue Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1066833?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 10229433 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1066833/0001144204-08-019048.txt#9667 Input fundies:Revenue: 25951443 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1066833/0001144204-08-019048.txt#9667
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 30.81 million

Prior period

−USD 38.37 million

2006-01-01 – 2006-12-31
Current period

−USD 7.56 million

2007-01-01 – 2007-12-31

Exact inputs and evidence

-7561739 − -38368362 = 30806623 USD

-38368362 USD · 2006-01-01 – 2006-12-31
Inspect prior input Prior source
-7561739 USD · 2007-01-01 – 2007-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Euthymics Bioscience, Inc. · 2007-12-31 Euthymics Bioscience, Inc. (edgar:1066833) Year-over-year change in Net income: 30806623 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1066833?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -7561739 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1066833/0001144204-08-019048.txt#11596 Input fundies:NetIncome: -38368362 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1066833/0001144204-08-019048.txt#11596
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 36.57 million

Prior period

−USD 51.48 million

2006-01-01 – 2006-12-31
Current period

−USD 14.92 million

2007-01-01 – 2007-12-31

Exact inputs and evidence

-14916506 − -51483570 = 36567064 USD

-51483570 USD · 2006-01-01 – 2006-12-31
Inspect prior input Prior source
-14916506 USD · 2007-01-01 – 2007-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Euthymics Bioscience, Inc. · 2007-12-31 Euthymics Bioscience, Inc. (edgar:1066833) Year-over-year change in Operating cash flow: 36567064 USD Concept: fundies:OperatingCashFlow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1066833?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -14916506 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1066833/0001144204-08-019048.txt#12053 Input fundies:OperatingCashFlow: -51483570 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1066833/0001144204-08-019048.txt#12053
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-100%

Prior period

USD 1.14 million

2006-01-01 – 2006-12-31
Current period

USD 0

2007-01-01 – 2007-12-31

Exact inputs and evidence

0 − 1144415 = -1144415 USD

1144415 USD · 2006-01-01 – 2006-12-31
Inspect prior input Prior source
0 USD · 2007-01-01 – 2007-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · Euthymics Bioscience, Inc. · 2007-12-31 Euthymics Bioscience, Inc. (edgar:1066833) Year-over-year change in Capital expenditure: -1144415 USD Concept: fundies:CapitalExpenditure Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1066833?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 0 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1066833/0001144204-08-019048.txt#12184 Input fundies:CapitalExpenditure: 1144415 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1066833/0001144204-08-019048.txt#12184
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2007 2007-01-01 – 2007-12-31

Revenue USD 10.23 million 100% of revenue
Operating costs Derived USD 28.59 million 279% of revenue
Operating income −USD 18.36 million −179% of revenue
Tax, interest and other Derived −USD 10.8 million −106% of revenue
Net income −USD 7.56 million −74% of revenue

Cash

Operating cash flow −USD 14.92 million −146% of revenue
Capital expenditure USD 0 0% of revenue
Free cash flow Derived −USD 14.92 million −146% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2000 Not shown: operating income or net income is not reported.
2001 Operating loss: operating costs were 157% of revenue.
2002 Operating loss: operating costs were 595% of revenue.
2003 Operating loss: operating costs were 972% of revenue.
2004 Operating loss: operating costs were 1,323% of revenue.
2005 Operating loss: operating costs were 730% of revenue.
2006 Operating loss: operating costs were 244% of revenue.
2007 Operating loss: operating costs were 279% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2000 2000-01-01 – 2000-12-31	0	3987478 Derived	-3987478	1946931 Derived	-5934409	-3426965 Derived	Source 2000-01-01 – 2000-12-31: 0 USD Inspect Revenue Open source 2000-01-01 – 2000-12-31: -3987478 USD Inspect Operating Income Open source 2000-01-01 – 2000-12-31: -5934409 USD Inspect Net Income Open source 2000-01-01 – 2000-12-31: -3301361 USD Inspect Operating Cash Flow Open source 2000-01-01 – 2000-12-31: 125604 USD Inspect Capital Expenditure Open source
2001 2001-01-01 – 2001-12-31	5711466	8979064 Derived	-3267598	2136599 Derived	-5404197	1643597 Derived	Source 2001-01-01 – 2001-12-31: 5711466 USD Inspect Revenue Open source 2001-01-01 – 2001-12-31: -3267598 USD Inspect Operating Income Open source 2001-01-01 – 2001-12-31: -5404197 USD Inspect Net Income Open source 2001-01-01 – 2001-12-31: 1725671 USD Inspect Operating Cash Flow Open source 2001-01-01 – 2001-12-31: 82074 USD Inspect Capital Expenditure Open source
2002 2002-01-01 – 2002-12-31	2389634	14213444 Derived	-11823810	4996662 Derived	-16820472	-11091362 Derived	Source 2002-01-01 – 2002-12-31: 2389634 USD Inspect Revenue Open source 2002-01-01 – 2002-12-31: -11823810 USD Inspect Operating Income Open source 2002-01-01 – 2002-12-31: -16820472 USD Inspect Net Income Open source 2002-01-01 – 2002-12-31: -10890304 USD Inspect Operating Cash Flow Open source 2002-01-01 – 2002-12-31: 201058 USD Inspect Capital Expenditure Open source
2003 2003-01-01 – 2003-12-31	2968750	28857440 Derived	-25888690	842657 Derived	-26731347	-18928624 Derived	Source 2003-01-01 – 2003-12-31: 2968750 USD Inspect Revenue Open source 2003-01-01 – 2003-12-31: -25888690 USD Inspect Operating Income Open source 2003-01-01 – 2003-12-31: -26731347 USD Inspect Net Income Open source 2003-01-01 – 2003-12-31: -18746816 USD Inspect Operating Cash Flow Open source 2003-01-01 – 2003-12-31: 181808 USD Inspect Capital Expenditure Open source
2004 2004-01-01 – 2004-12-31	2542381	33624276 Derived	-31081895	1838709 Derived	-32920604	7462279 Derived	Source 2004-01-01 – 2004-12-31: 2542381 USD Inspect Revenue Open source 2004-01-01 – 2004-12-31: -31081895 USD Inspect Operating Income Open source 2004-01-01 – 2004-12-31: -32920604 USD Inspect Net Income Open source 2004-01-01 – 2004-12-31: 7794857 USD Inspect Operating Cash Flow Open source 2004-01-01 – 2004-12-31: 332578 USD Inspect Capital Expenditure Open source
2005 2005-01-01 – 2005-12-31	8646596	63093043 Derived	-54446447	-1478611 Derived	-52967836	-48932182 Derived	Source 2005-01-01 – 2005-12-31: 8646596 USD Inspect Revenue Open source 2005-01-01 – 2005-12-31: -54446447 USD Inspect Operating Income Open source 2005-01-01 – 2005-12-31: -52967836 USD Inspect Net Income Open source 2005-01-01 – 2005-12-31: -48253911 USD Inspect Operating Cash Flow Open source 2005-01-01 – 2005-12-31: 678271 USD Inspect Capital Expenditure Open source
2006 2006-01-01 – 2006-12-31	25951443	63340872 Derived	-37389429	978933 Derived	-38368362	-52627985 Derived	Source 2006-01-01 – 2006-12-31: 25951443 USD Inspect Revenue Open source 2006-01-01 – 2006-12-31: -37389429 USD Inspect Operating Income Open source 2006-01-01 – 2006-12-31: -38368362 USD Inspect Net Income Open source 2006-01-01 – 2006-12-31: -51483570 USD Inspect Operating Cash Flow Open source 2006-01-01 – 2006-12-31: 1144415 USD Inspect Capital Expenditure Open source
2007 2007-01-01 – 2007-12-31	10229433	28589283 Derived	-18359850	-10798111 Derived	-7561739	-14916506 Derived	Source 2007-01-01 – 2007-12-31: 10229433 USD Inspect Revenue Open source 2007-01-01 – 2007-12-31: -18359850 USD Inspect Operating Income Open source 2007-01-01 – 2007-12-31: -7561739 USD Inspect Net Income Open source 2007-01-01 – 2007-12-31: -14916506 USD Inspect Operating Cash Flow Open source 2007-01-01 – 2007-12-31: 0 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 10.2M 2007

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20002000-12-31	Revenue	0	Revenue: 0 Open source
20012001-12-31	Revenue	5711466	Revenue: 5711466 Open source
20022002-12-31	Revenue	2389634	Revenue: 2389634 Open source
20032003-12-31	Revenue	2968750	Revenue: 2968750 Open source
20042004-12-31	Revenue	2542381	Revenue: 2542381 Open source
20052005-12-31	Revenue	8646596	Revenue: 8646596 Open source
20062006-12-31	Revenue	25951443	Revenue: 25951443 Open source
20072007-12-31	Revenue	10229433	Revenue: 10229433 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-60.6% 2007

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20002000-12-31	Year over year	No prior comparable period	Revenue: 0 Open source
20012001-12-31	Year over year	No prior comparable period	Revenue: 5711466 Open source Revenue: 0 Open source
20022002-12-31	Year over year	-58.2%	Revenue: 2389634 Open source Revenue: 5711466 Open source
20032003-12-31	Year over year	24.2%	Revenue: 2968750 Open source Revenue: 2389634 Open source
20042004-12-31	Year over year	-14.4%	Revenue: 2542381 Open source Revenue: 2968750 Open source
20052005-12-31	Year over year	240.1%	Revenue: 8646596 Open source Revenue: 2542381 Open source
20062006-12-31	Year over year	200.1%	Revenue: 25951443 Open source Revenue: 8646596 Open source
20072007-12-31	Year over year	-60.6%	Revenue: 10229433 Open source Revenue: 25951443 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -179.5% 2007

Net margin -73.9% 2007

Free cash flow margin -145.8% 2007

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20002000-12-31	Operating margin	Not reported	Operating Income: -3987478 Open source Revenue: 0 Open source
20012001-12-31	Operating margin	-57.2%	Operating Income: -3267598 Open source Revenue: 5711466 Open source
20022002-12-31	Operating margin	-494.8%	Operating Income: -11823810 Open source Revenue: 2389634 Open source
20032003-12-31	Operating margin	-872%	Operating Income: -25888690 Open source Revenue: 2968750 Open source
20042004-12-31	Operating margin	-1,222.6%	Operating Income: -31081895 Open source Revenue: 2542381 Open source
20052005-12-31	Operating margin	-629.7%	Operating Income: -54446447 Open source Revenue: 8646596 Open source
20062006-12-31	Operating margin	-144.1%	Operating Income: -37389429 Open source Revenue: 25951443 Open source
20072007-12-31	Operating margin	-179.5%	Operating Income: -18359850 Open source Revenue: 10229433 Open source
20002000-12-31	Net margin	Not reported	Net Income: -5934409 Open source Revenue: 0 Open source
20012001-12-31	Net margin	-94.6%	Net Income: -5404197 Open source Revenue: 5711466 Open source
20022002-12-31	Net margin	-703.9%	Net Income: -16820472 Open source Revenue: 2389634 Open source
20032003-12-31	Net margin	-900.4%	Net Income: -26731347 Open source Revenue: 2968750 Open source
20042004-12-31	Net margin	-1,294.9%	Net Income: -32920604 Open source Revenue: 2542381 Open source
20052005-12-31	Net margin	-612.6%	Net Income: -52967836 Open source Revenue: 8646596 Open source
20062006-12-31	Net margin	-147.8%	Net Income: -38368362 Open source Revenue: 25951443 Open source
20072007-12-31	Net margin	-73.9%	Net Income: -7561739 Open source Revenue: 10229433 Open source
20002000-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -3301361 Open source Capital Expenditure: 125604 Open source
20012001-12-31	Free cash flow margin	28.8%	Revenue: 5711466 Open source Operating Cash Flow: 1725671 Open source Capital Expenditure: 82074 Open source
20022002-12-31	Free cash flow margin	-464.1%	Revenue: 2389634 Open source Operating Cash Flow: -10890304 Open source Capital Expenditure: 201058 Open source
20032003-12-31	Free cash flow margin	-637.6%	Revenue: 2968750 Open source Operating Cash Flow: -18746816 Open source Capital Expenditure: 181808 Open source
20042004-12-31	Free cash flow margin	293.5%	Revenue: 2542381 Open source Operating Cash Flow: 7794857 Open source Capital Expenditure: 332578 Open source
20052005-12-31	Free cash flow margin	-565.9%	Revenue: 8646596 Open source Operating Cash Flow: -48253911 Open source Capital Expenditure: 678271 Open source
20062006-12-31	Free cash flow margin	-202.8%	Revenue: 25951443 Open source Operating Cash Flow: -51483570 Open source Capital Expenditure: 1144415 Open source
20072007-12-31	Free cash flow margin	-145.8%	Revenue: 10229433 Open source Operating Cash Flow: -14916506 Open source Capital Expenditure: 0 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -14.9M 2007

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20002000-12-31	Operating cash flow	-3301361	Operating Cash Flow: -3301361 Open source
20012001-12-31	Operating cash flow	1725671	Operating Cash Flow: 1725671 Open source
20022002-12-31	Operating cash flow	-10890304	Operating Cash Flow: -10890304 Open source
20032003-12-31	Operating cash flow	-18746816	Operating Cash Flow: -18746816 Open source
20042004-12-31	Operating cash flow	7794857	Operating Cash Flow: 7794857 Open source
20052005-12-31	Operating cash flow	-48253911	Operating Cash Flow: -48253911 Open source
20062006-12-31	Operating cash flow	-51483570	Operating Cash Flow: -51483570 Open source
20072007-12-31	Operating cash flow	-14916506	Operating Cash Flow: -14916506 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -14.9M 2007

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20002000-12-31	Free cash flow	-3426965	Operating Cash Flow: -3301361 Open source Capital Expenditure: 125604 Open source
20012001-12-31	Free cash flow	1643597	Operating Cash Flow: 1725671 Open source Capital Expenditure: 82074 Open source
20022002-12-31	Free cash flow	-11091362	Operating Cash Flow: -10890304 Open source Capital Expenditure: 201058 Open source
20032003-12-31	Free cash flow	-18928624	Operating Cash Flow: -18746816 Open source Capital Expenditure: 181808 Open source
20042004-12-31	Free cash flow	7462279	Operating Cash Flow: 7794857 Open source Capital Expenditure: 332578 Open source
20052005-12-31	Free cash flow	-48932182	Operating Cash Flow: -48253911 Open source Capital Expenditure: 678271 Open source
20062006-12-31	Free cash flow	-52627985	Operating Cash Flow: -51483570 Open source Capital Expenditure: 1144415 Open source
20072007-12-31	Free cash flow	-14916506	Operating Cash Flow: -14916506 Open source Capital Expenditure: 0 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2000-12-31	Liabilities / assets	Not reported	No source recorded
2001-12-31	Liabilities / assets	Not reported	Total Assets: 18080029 Open source
2002-12-31	Liabilities / assets	Not reported	Total Assets: 66150447 Open source
2003-12-31	Liabilities / assets	Not reported	Total Assets: 53851860 Open source
2004-12-31	Liabilities / assets	Not reported	Total Assets: 136722553 Open source
2005-12-31	Liabilities / assets	Not reported	Total Assets: 102186506 Open source
2006-12-31	Liabilities / assets	Not reported	Total Assets: 50361322 Open source
2007-12-31	Liabilities / assets	Not reported	Total Assets: 15530464 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

5.2× 2007

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2000-12-31	Current assets / current liabilities	Not reported	No source recorded
20012001-12-31	Current assets / current liabilities	3.05×	Current Assets: 17604767 Open source Current Liabilities: 5774021 Open source
20022002-12-31	Current assets / current liabilities	6.1×	Current Assets: 64714903 Open source Current Liabilities: 10601184 Open source
20032003-12-31	Current assets / current liabilities	16.2×	Current Assets: 49576671 Open source Current Liabilities: 3060469 Open source
20042004-12-31	Current assets / current liabilities	5.7×	Current Assets: 110757931 Open source Current Liabilities: 19423476 Open source
20052005-12-31	Current assets / current liabilities	4.73×	Current Assets: 99563438 Open source Current Liabilities: 21047904 Open source
20062006-12-31	Current assets / current liabilities	1.89×	Current Assets: 44936024 Open source Current Liabilities: 23798648 Open source
20072007-12-31	Current assets / current liabilities	5.2×	Current Assets: 10419395 Open source Current Liabilities: 2005263 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2000 2000-01-01 – 2000-12-31	−USD 5.93 million Exact value Exact value: -5934409 USD 2000-01-01 – 2000-12-31: -5934409 USD Inspect Net Income Open source Share or cite Citation for Net Income · Euthymics Bioscience, Inc. · 2000-12-31 Euthymics Bioscience, Inc. (edgar:1066833) Net Income: -5934409 USD Concept: fundies:NetIncome Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1066833/explain?concept=fundies%3ANetIncome&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:NetIncome: -5934409 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1066833/0000912057-03-000163.txt#6359 The citation records this snapshot. The page link may show a newer release later.	−USD 3.3 million Exact value Exact value: -3301361 USD 2000-01-01 – 2000-12-31: -3301361 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Euthymics Bioscience, Inc. · 2000-12-31 Euthymics Bioscience, Inc. (edgar:1066833) Operating Cash Flow: -3301361 USD Concept: fundies:OperatingCashFlow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1066833/explain?concept=fundies%3AOperatingCashFlow&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -3301361 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1066833/0000912057-03-000163.txt#6625 The citation records this snapshot. The page link may show a newer release later.	USD 125,604 Exact value Exact value: 125604 USD 2000-01-01 – 2000-12-31: 125604 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Euthymics Bioscience, Inc. · 2000-12-31 Euthymics Bioscience, Inc. (edgar:1066833) Capital Expenditure: 125604 USD Concept: fundies:CapitalExpenditure Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1066833/explain?concept=fundies%3ACapitalExpenditure&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 125604 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1066833/0000912057-03-000163.txt#6701 The citation records this snapshot. The page link may show a newer release later.	−USD 3.43 million Calculation and evidence -3301361 − 125604 USD Exact free cash flow: -3426965 USD 2000-01-01 – 2000-12-31: -3301361 USD · Inspect Operating Cash Flow · Source 2000-01-01 – 2000-12-31: 125604 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Euthymics Bioscience, Inc. · 2000-12-31 Euthymics Bioscience, Inc. (edgar:1066833) Free cash flow: -3426965 USD Concept: free-cash-flow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1066833?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -3301361 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1066833/0000912057-03-000163.txt#6625 Input fundies:CapitalExpenditure: 125604 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1066833/0000912057-03-000163.txt#6701 The citation records this snapshot. The page link may show a newer release later.
2001 2001-01-01 – 2001-12-31	−USD 5.4 million Exact value Exact value: -5404197 USD 2001-01-01 – 2001-12-31: -5404197 USD Inspect Net Income Open source Share or cite Citation for Net Income · Euthymics Bioscience, Inc. · 2001-12-31 Euthymics Bioscience, Inc. (edgar:1066833) Net Income: -5404197 USD Concept: fundies:NetIncome Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1066833/explain?concept=fundies%3ANetIncome&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:NetIncome: -5404197 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1066833/0001144204-04-002979.txt#8924 The citation records this snapshot. The page link may show a newer release later.	USD 1.73 million Exact value Exact value: 1725671 USD 2001-01-01 – 2001-12-31: 1725671 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Euthymics Bioscience, Inc. · 2001-12-31 Euthymics Bioscience, Inc. (edgar:1066833) Operating Cash Flow: 1725671 USD Concept: fundies:OperatingCashFlow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1066833/explain?concept=fundies%3AOperatingCashFlow&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 1725671 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1066833/0001144204-04-002979.txt#9304 The citation records this snapshot. The page link may show a newer release later.	USD 82,074 Exact value Exact value: 82074 USD 2001-01-01 – 2001-12-31: 82074 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Euthymics Bioscience, Inc. · 2001-12-31 Euthymics Bioscience, Inc. (edgar:1066833) Capital Expenditure: 82074 USD Concept: fundies:CapitalExpenditure Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1066833/explain?concept=fundies%3ACapitalExpenditure&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 82074 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1066833/0001144204-04-002979.txt#9438 The citation records this snapshot. The page link may show a newer release later.	USD 1.64 million Calculation and evidence 1725671 − 82074 USD Exact free cash flow: 1643597 USD 2001-01-01 – 2001-12-31: 1725671 USD · Inspect Operating Cash Flow · Source 2001-01-01 – 2001-12-31: 82074 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Euthymics Bioscience, Inc. · 2001-12-31 Euthymics Bioscience, Inc. (edgar:1066833) Free cash flow: 1643597 USD Concept: free-cash-flow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1066833?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 1725671 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1066833/0001144204-04-002979.txt#9304 Input fundies:CapitalExpenditure: 82074 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1066833/0001144204-04-002979.txt#9438 The citation records this snapshot. The page link may show a newer release later.
2002 2002-01-01 – 2002-12-31	−USD 16.82 million Exact value Exact value: -16820472 USD 2002-01-01 – 2002-12-31: -16820472 USD Inspect Net Income Open source Share or cite Citation for Net Income · Euthymics Bioscience, Inc. · 2002-12-31 Euthymics Bioscience, Inc. (edgar:1066833) Net Income: -16820472 USD Concept: fundies:NetIncome Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1066833/explain?concept=fundies%3ANetIncome&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:NetIncome: -16820472 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1066833/0001144204-05-007614.txt#22168 The citation records this snapshot. The page link may show a newer release later.	−USD 10.89 million Exact value Exact value: -10890304 USD 2002-01-01 – 2002-12-31: -10890304 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Euthymics Bioscience, Inc. · 2002-12-31 Euthymics Bioscience, Inc. (edgar:1066833) Operating Cash Flow: -10890304 USD Concept: fundies:OperatingCashFlow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1066833/explain?concept=fundies%3AOperatingCashFlow&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -10890304 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1066833/0001144204-05-007614.txt#22886 The citation records this snapshot. The page link may show a newer release later.	USD 201,058 Exact value Exact value: 201058 USD 2002-01-01 – 2002-12-31: 201058 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Euthymics Bioscience, Inc. · 2002-12-31 Euthymics Bioscience, Inc. (edgar:1066833) Capital Expenditure: 201058 USD Concept: fundies:CapitalExpenditure Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1066833/explain?concept=fundies%3ACapitalExpenditure&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 201058 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1066833/0001144204-05-007614.txt#23146 The citation records this snapshot. The page link may show a newer release later.	−USD 11.09 million Calculation and evidence -10890304 − 201058 USD Exact free cash flow: -11091362 USD 2002-01-01 – 2002-12-31: -10890304 USD · Inspect Operating Cash Flow · Source 2002-01-01 – 2002-12-31: 201058 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Euthymics Bioscience, Inc. · 2002-12-31 Euthymics Bioscience, Inc. (edgar:1066833) Free cash flow: -11091362 USD Concept: free-cash-flow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1066833?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -10890304 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1066833/0001144204-05-007614.txt#22886 Input fundies:CapitalExpenditure: 201058 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1066833/0001144204-05-007614.txt#23146 The citation records this snapshot. The page link may show a newer release later.
2003 2003-01-01 – 2003-12-31	−USD 26.73 million Exact value Exact value: -26731347 USD 2003-01-01 – 2003-12-31: -26731347 USD Inspect Net Income Open source Share or cite Citation for Net Income · Euthymics Bioscience, Inc. · 2003-12-31 Euthymics Bioscience, Inc. (edgar:1066833) Net Income: -26731347 USD Concept: fundies:NetIncome Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1066833/explain?concept=fundies%3ANetIncome&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:NetIncome: -26731347 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1066833/0001144204-06-009961.txt#17998 The citation records this snapshot. The page link may show a newer release later.	−USD 18.75 million Exact value Exact value: -18746816 USD 2003-01-01 – 2003-12-31: -18746816 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Euthymics Bioscience, Inc. · 2003-12-31 Euthymics Bioscience, Inc. (edgar:1066833) Operating Cash Flow: -18746816 USD Concept: fundies:OperatingCashFlow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1066833/explain?concept=fundies%3AOperatingCashFlow&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -18746816 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1066833/0001144204-06-009961.txt#18457 The citation records this snapshot. The page link may show a newer release later.	USD 181,808 Exact value Exact value: 181808 USD 2003-01-01 – 2003-12-31: 181808 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Euthymics Bioscience, Inc. · 2003-12-31 Euthymics Bioscience, Inc. (edgar:1066833) Capital Expenditure: 181808 USD Concept: fundies:CapitalExpenditure Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1066833/explain?concept=fundies%3ACapitalExpenditure&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 181808 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1066833/0001144204-06-009961.txt#18608 The citation records this snapshot. The page link may show a newer release later.	−USD 18.93 million Calculation and evidence -18746816 − 181808 USD Exact free cash flow: -18928624 USD 2003-01-01 – 2003-12-31: -18746816 USD · Inspect Operating Cash Flow · Source 2003-01-01 – 2003-12-31: 181808 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Euthymics Bioscience, Inc. · 2003-12-31 Euthymics Bioscience, Inc. (edgar:1066833) Free cash flow: -18928624 USD Concept: free-cash-flow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1066833?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -18746816 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1066833/0001144204-06-009961.txt#18457 Input fundies:CapitalExpenditure: 181808 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1066833/0001144204-06-009961.txt#18608 The citation records this snapshot. The page link may show a newer release later.
2004 2004-01-01 – 2004-12-31	−USD 32.92 million Exact value Exact value: -32920604 USD 2004-01-01 – 2004-12-31: -32920604 USD Inspect Net Income Open source Share or cite Citation for Net Income · Euthymics Bioscience, Inc. · 2004-12-31 Euthymics Bioscience, Inc. (edgar:1066833) Net Income: -32920604 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1066833/explain?concept=fundies%3ANetIncome&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:NetIncome: -32920604 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1066833/0001144204-07-015807.txt#22686 The citation records this snapshot. The page link may show a newer release later.	USD 7.79 million Exact value Exact value: 7794857 USD 2004-01-01 – 2004-12-31: 7794857 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Euthymics Bioscience, Inc. · 2004-12-31 Euthymics Bioscience, Inc. (edgar:1066833) Operating Cash Flow: 7794857 USD Concept: fundies:OperatingCashFlow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1066833/explain?concept=fundies%3AOperatingCashFlow&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 7794857 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1066833/0001144204-07-015807.txt#23055 The citation records this snapshot. The page link may show a newer release later.	USD 332,578 Exact value Exact value: 332578 USD 2004-01-01 – 2004-12-31: 332578 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Euthymics Bioscience, Inc. · 2004-12-31 Euthymics Bioscience, Inc. (edgar:1066833) Capital Expenditure: 332578 USD Concept: fundies:CapitalExpenditure Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1066833/explain?concept=fundies%3ACapitalExpenditure&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 332578 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1066833/0001144204-07-015807.txt#23184 The citation records this snapshot. The page link may show a newer release later.	USD 7.46 million Calculation and evidence 7794857 − 332578 USD Exact free cash flow: 7462279 USD 2004-01-01 – 2004-12-31: 7794857 USD · Inspect Operating Cash Flow · Source 2004-01-01 – 2004-12-31: 332578 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Euthymics Bioscience, Inc. · 2004-12-31 Euthymics Bioscience, Inc. (edgar:1066833) Free cash flow: 7462279 USD Concept: free-cash-flow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1066833?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 7794857 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1066833/0001144204-07-015807.txt#23055 Input fundies:CapitalExpenditure: 332578 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1066833/0001144204-07-015807.txt#23184 The citation records this snapshot. The page link may show a newer release later.
2005 2005-01-01 – 2005-12-31	−USD 52.97 million Exact value Exact value: -52967836 USD 2005-01-01 – 2005-12-31: -52967836 USD Inspect Net Income Open source Share or cite Citation for Net Income · Euthymics Bioscience, Inc. · 2005-12-31 Euthymics Bioscience, Inc. (edgar:1066833) Net Income: -52967836 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1066833/explain?concept=fundies%3ANetIncome&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:NetIncome: -52967836 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1066833/0001144204-08-019048.txt#11596 The citation records this snapshot. The page link may show a newer release later.	−USD 48.25 million Exact value Exact value: -48253911 USD 2005-01-01 – 2005-12-31: -48253911 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Euthymics Bioscience, Inc. · 2005-12-31 Euthymics Bioscience, Inc. (edgar:1066833) Operating Cash Flow: -48253911 USD Concept: fundies:OperatingCashFlow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1066833/explain?concept=fundies%3AOperatingCashFlow&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -48253911 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1066833/0001144204-08-019048.txt#12053 The citation records this snapshot. The page link may show a newer release later.	USD 678,271 Exact value Exact value: 678271 USD 2005-01-01 – 2005-12-31: 678271 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Euthymics Bioscience, Inc. · 2005-12-31 Euthymics Bioscience, Inc. (edgar:1066833) Capital Expenditure: 678271 USD Concept: fundies:CapitalExpenditure Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1066833/explain?concept=fundies%3ACapitalExpenditure&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 678271 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1066833/0001144204-08-019048.txt#12184 The citation records this snapshot. The page link may show a newer release later.	−USD 48.93 million Calculation and evidence -48253911 − 678271 USD Exact free cash flow: -48932182 USD 2005-01-01 – 2005-12-31: -48253911 USD · Inspect Operating Cash Flow · Source 2005-01-01 – 2005-12-31: 678271 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Euthymics Bioscience, Inc. · 2005-12-31 Euthymics Bioscience, Inc. (edgar:1066833) Free cash flow: -48932182 USD Concept: free-cash-flow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1066833?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -48253911 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1066833/0001144204-08-019048.txt#12053 Input fundies:CapitalExpenditure: 678271 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1066833/0001144204-08-019048.txt#12184 The citation records this snapshot. The page link may show a newer release later.
2006 2006-01-01 – 2006-12-31	−USD 38.37 million Exact value Exact value: -38368362 USD 2006-01-01 – 2006-12-31: -38368362 USD Inspect Net Income Open source Share or cite Citation for Net Income · Euthymics Bioscience, Inc. · 2006-12-31 Euthymics Bioscience, Inc. (edgar:1066833) Net Income: -38368362 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1066833/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: -38368362 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1066833/0001144204-08-019048.txt#11596 The citation records this snapshot. The page link may show a newer release later.	−USD 51.48 million Exact value Exact value: -51483570 USD 2006-01-01 – 2006-12-31: -51483570 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Euthymics Bioscience, Inc. · 2006-12-31 Euthymics Bioscience, Inc. (edgar:1066833) Operating Cash Flow: -51483570 USD Concept: fundies:OperatingCashFlow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1066833/explain?concept=fundies%3AOperatingCashFlow&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -51483570 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1066833/0001144204-08-019048.txt#12053 The citation records this snapshot. The page link may show a newer release later.	USD 1.14 million Exact value Exact value: 1144415 USD 2006-01-01 – 2006-12-31: 1144415 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Euthymics Bioscience, Inc. · 2006-12-31 Euthymics Bioscience, Inc. (edgar:1066833) Capital Expenditure: 1144415 USD Concept: fundies:CapitalExpenditure Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1066833/explain?concept=fundies%3ACapitalExpenditure&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1144415 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1066833/0001144204-08-019048.txt#12184 The citation records this snapshot. The page link may show a newer release later.	−USD 52.63 million Calculation and evidence -51483570 − 1144415 USD Exact free cash flow: -52627985 USD 2006-01-01 – 2006-12-31: -51483570 USD · Inspect Operating Cash Flow · Source 2006-01-01 – 2006-12-31: 1144415 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Euthymics Bioscience, Inc. · 2006-12-31 Euthymics Bioscience, Inc. (edgar:1066833) Free cash flow: -52627985 USD Concept: free-cash-flow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1066833?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -51483570 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1066833/0001144204-08-019048.txt#12053 Input fundies:CapitalExpenditure: 1144415 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1066833/0001144204-08-019048.txt#12184 The citation records this snapshot. The page link may show a newer release later.
2007 2007-01-01 – 2007-12-31	−USD 7.56 million Exact value Exact value: -7561739 USD 2007-01-01 – 2007-12-31: -7561739 USD Inspect Net Income Open source Share or cite Citation for Net Income · Euthymics Bioscience, Inc. · 2007-12-31 Euthymics Bioscience, Inc. (edgar:1066833) Net Income: -7561739 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1066833/explain?concept=fundies%3ANetIncome&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:NetIncome: -7561739 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1066833/0001144204-08-019048.txt#11596 The citation records this snapshot. The page link may show a newer release later.	−USD 14.92 million Exact value Exact value: -14916506 USD 2007-01-01 – 2007-12-31: -14916506 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Euthymics Bioscience, Inc. · 2007-12-31 Euthymics Bioscience, Inc. (edgar:1066833) Operating Cash Flow: -14916506 USD Concept: fundies:OperatingCashFlow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1066833/explain?concept=fundies%3AOperatingCashFlow&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -14916506 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1066833/0001144204-08-019048.txt#12053 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2007-01-01 – 2007-12-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Euthymics Bioscience, Inc. · 2007-12-31 Euthymics Bioscience, Inc. (edgar:1066833) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1066833/explain?concept=fundies%3ACapitalExpenditure&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1066833/0001144204-08-019048.txt#12184 The citation records this snapshot. The page link may show a newer release later.	−USD 14.92 million Calculation and evidence -14916506 − 0 USD Exact free cash flow: -14916506 USD 2007-01-01 – 2007-12-31: -14916506 USD · Inspect Operating Cash Flow · Source 2007-01-01 – 2007-12-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Euthymics Bioscience, Inc. · 2007-12-31 Euthymics Bioscience, Inc. (edgar:1066833) Free cash flow: -14916506 USD Concept: free-cash-flow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1066833?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -14916506 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1066833/0001144204-08-019048.txt#12053 Input fundies:CapitalExpenditure: 0 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1066833/0001144204-08-019048.txt#12184 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

32 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001066833, 1066833, edgar:1066833

Also known as DOV PHARMACEUTICAL INC, Euthymics Bioscience Inc

Euthymics Bioscience, Inc.

Latest quarter

Revenue

Operating margin

Operating cash flow

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2007 2007-01-01 – 2007-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation